BRAF molecular testing in cytopathology: Implications for diagnosis, prognosis, and targeted therapeutics.

Bergdorf KN, Lee LA, Weiss VL
Cancer Cytopathol. 2020 128 (1): 9-11

PMID: 31765065 · DOI:10.1002/cncy.22209

MeSH Terms (11)

Antineoplastic Agents Genetic Testing Humans MAP Kinase Signaling System Molecular Targeted Therapy Mutation Neoplasms Phosphorylation Precision Medicine Prognosis Proto-Oncogene Proteins B-raf

Connections (1)

This publication is referenced by other Labnodes entities:

Links